NeuroOne Medical Technologies (NMTC) Balance Sheet: Assets & Liabilities

NeuroOne Medical Technologies (NMTC) Balance Sheet

As of Sep 30, 2025 (end of fiscal 2025), NeuroOne Medical Technologies reported total assets of $10.79M and total liabilities of $3.71M. Shareholders' equity was $7.07M, up 760.4% from $822.01K a year earlier. Total debt stood at $266.81K against $6.57M in cash and short-term investments, a net cash position of $6.30M. That puts debt-to-equity at 0.04, compared with 0.32 a year earlier.

NeuroOne Medical Technologies Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for NeuroOne Medical Technologies Corporation (NMTC) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Sep 2025	Sep 2024	Sep 2023	Sep 2022	Sep 2021	Sep 2020	Sep 2019	Sep 2018	Dec 2017
Current Assets
Cash and Cash Equivalents	6.57	1.46	5.32	8.16	6.90	4.04	0.26	0.01	0.03
Short-Term Investments	0.00	0.00	0.00	2.98	0.00	0.00	0.00	0.00	0.00
Cash & Short-Term Investments	6.57	1.46	5.32	11.14	6.90	4.04	0.26	0.01	0.03
Accounts Receivable	1.26	0.18	0.00	0.03	0.05	0.00	0.00	0.00	0.00
Inventory	2.23	2.64	1.73	0.70	0.10	0.00	0.00	0.00	0.00
Other Current Assets	0.16	0.36	0.26	0.30	0.24	0.12	0.04	0.01	0.01
Total Current Assets	10.23	4.63	7.31	12.18	7.29	4.16	0.30	0.02	0.03
Non-Current Assets
Property, Plant & Equipment (Net)	0.51	0.67	0.69	0.53	0.51	0.45	0.05	0.00	0.00
Intangible Assets	0.04	0.07	0.09	0.11	0.13	0.16	0.18	0.20	0.22
Other Non-Current Assets	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Non-Current Assets	0.56	0.74	0.78	0.65	0.65	0.60	0.23	0.20	0.22
Total Assets	10.79	5.37	8.10	12.82	7.94	4.76	0.53	0.22	0.25
Current Liabilities
Accounts Payable	1.01	1.03	0.69	0.93	0.53	0.76	1.15	0.22	0.00
Short-Term Debt	0.12	0.07	0.13	0.08	0.11	1.07	0.00	1.68	2.42
Accrued Liabilities	1.17	1.06	0.98	0.72	0.64	-	-	-	-
Deferred Revenue	0.00	0.00	0.00	1.46	0.01	0.07	0.00	0.00	0.00
Other Current Liabilities	1.17	0.06	0.98	0.63	0.53	0.45	0.50	2.10	2.28
Total Current Liabilities	2.30	2.21	1.79	3.10	1.18	2.36	1.77	3.80	3.91
Non-Current Liabilities
Long-Term Debt	0.14	0.19	0.06	0.12	0.20	0.25	0.00	0.00	0.00
Other Non-Current Liabilities	1.27	2.14	0.00	0.00	0.00	0.08	0.00	0.82	1.38
Total Non-Current Liabilities	1.41	2.33	0.06	0.12	0.20	0.34	0.00	0.82	1.38
Total Liabilities	3.71	4.55	1.85	3.22	1.38	2.69	1.77	4.61	5.29
Stockholders' Equity
Common Stock	0.05	0.03	0.02	0.02	0.01	0.02	0.01	0.01	0.01
Retained Earnings	-78.61	-75.00	-62.69	-50.83	-40.83	-30.88	-17.24	-10.46	-5.32
Additional Paid-in Capital	85.63	75.80	68.91	60.41	47.37	32.92	15.99	6.05	0.28
Shares Outstanding	8.33	5.14	3.99	2.70	-	-	-	-	-
Total Stockholders' Equity	7.07	0.82	6.25	9.60	6.55	2.07	-1.24	-4.40	-5.04
Total Liabilities & Equity	10.79	5.37	8.10	12.82	7.94	4.76	0.53	0.22	0.25

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About NeuroOne Medical Technologies Balance Sheet

How much debt does NeuroOne Medical Technologies have?

NeuroOne Medical Technologies had total debt of $266.81K as of Sep 30, 2025, against $6.57M in cash and short-term investments. Its debt-to-equity ratio was 0.04. Total debt was $260.16K a year earlier.

What are NeuroOne Medical Technologies's total assets?

NeuroOne Medical Technologies reported total assets of $10.79M as of Sep 30, 2025, up 100.9% from $5.37M a year earlier. Total liabilities were $3.71M.

What is NeuroOne Medical Technologies's shareholders' equity?

NeuroOne Medical Technologies's shareholders' equity was $7.07M as of Sep 30, 2025, or about $0.85 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition